76Bio

76Bio is a biotechnology company that develops therapies for patients with life-threatening diseases.

Based based in Greater New York Area, East Coast, Northeastern US, 76Bio works in biotechnology, health care, medical, therapeutics, founded in 2020.

Its activity falls under biotechnology, health care, medical, therapeutics; the profile below is assembled from public directory data.

Greater New York Area, East Coast, Northeastern US is where the company is located.

Its current recorded stage is Series_Unknown.

The company reports a headcount in the c_00011_00050 range.

It has disclosed roughly $10M in funding.

Sector	Biotechnology, Health Care, Medical, Therapeutics
Headquarters	Greater New York Area, East Coast, Northeastern US
Founded	2020
Employees	c_00011_00050
Stage	series_unknown
Total funding	$10,005,244

Website: www.76bio.com

Browse related